Dialysis After Lung Transplantation: Prevalence, Risk Factors and Outcome

Journal of Heart and Lung Transplantation

Volumn 26, Issue 11, 2007, Pages 1155-1162

  Mason, David P ^a   Solovera Rozas, Maria ^a   Feng, Jingyuan ^a   Rajeswaran, Jeevanantham ^a   Thuita, Lucy ^a   Murthy, Sudish C ^a   Budev, Marie M ^b   Mehta, Atul C ^b   Haug III, Marcus ^a   McNeill, Ann M ^a   Pettersson, Gösta B ^a   Blackstone, Eugene H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Allergy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; TACROLIMUS;

ARTICLE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DEMOGRAPHY; DIALYSIS; DRUG DOSE REDUCTION; FEMALE; GRAFT SURVIVAL; HEAD INJURY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LUNG TOXICITY; LUNG TRANSPLANTATION; MALE; NEPHROTOXICITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR;

ADULT; CALCINEURIN; CREATININE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 36048986345     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.08.006     Document Type: Article

References (33)

1. Trulock E.P., Edwards L.B., Taylor D.O., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report-2006. J Heart Lung Transplant 25 (2006) 880-892
2. Ojo A.O., Held P.J., Port F.K., et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349 (2003) 931-940
3. Barraclough K., Menahem S.A., Bailey M., and Thomson N.M. Predictors of decline in renal function after lung transplantation. J Heart Lung Transplant 25 (2006) 1431-1435
4. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
5. Wheeler L.A., and Sheiner L.B. Clinical estimation of creatinine clearance. Am J Clin Pathol 72 (1979) 27-32
6. Diggle P.J., Heagerty P.J., Liang K.Y., and Zeger S.L. Analysis of longitudinal data. 2nd ed. (2002), Oxford University Press, New York
7. Blackstone E.H., Naftel D.C., and Turner Jr. M.E. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc 81 (1986) 615-624
8. Breiman L. Bagging predictors. Machine Learning 24 (1996) 123-140
9. Blackstone E.H. Breaking down barriers: helpful breakthrough statistical methods you need to understand better. J Thorac Cardiovasc Surg 122 (2001) 430-439
10. Griffiths M.H., Crowe A.V., Papadaki L., et al. Cyclosporin nephrotoxicity in heart and lung transplant patients. Q J Med 89 (1996) 751-763
11. Fisher N.C. Renal failure after lung transplantation. Lancet 352 (1998) 69-70
12. Rocha P.N., Rocha A.T., Palmer S.M., Davis R.D., and Smith S.R. Acute renal failure after lung transplantation: incidence, predictors and impact on perioperative morbidity and mortality. Am J Transplant 5 (2005) 1469-1476
13. Hmiel S.P., Beck A.M., de la Morena M.T., and Sweet S. Progressive chronic kidney disease after pediatric lung transplantation. Am J Transplant 5 (2005) 1739-1747
14. Broekroelofs J., Stegeman C.A., Navis G., and de Jong P.E. Prevention of renal function loss after non-renal solid organ transplantation-how can nephrologists help to keep the kidneys out of the line of fire?. Nephrol Dial Transplant 14 (1999) 1841-1843
15. Ishani A., Erturk S., Hertz M.I., et al. Predictors of renal function following lung or heart-lung transplantation. Kidney Int 61 (2002) 2228-2234
16. Sekine Y., Waddell T.K., Matte-Martyn A., et al. Risk quantification of early outcome after lung transplantation: donor, recipient, operative, and post-transplant parameters. J Heart Lung Transplant 23 (2004) 96-104
17. Canales M., Youssef P., Spong R., et al. Predictors of chronic kidney disease in long-term survivors of lung and heart-lung transplantation. Am J Transplant 6 (2006) 2157-2163
18. Wyatt C.M., and Arons R.R. The burden of acute renal failure in nonrenal solid organ transplantation. Transplantation 78 (2004) 1351-1355
19. Broekroelofs J., Navis G.J., Stegeman C.A., et al. Long-term renal outcome after lung transplantation is predicted by the 1-month postoperative renal function loss. Transplantation 69 (2000) 1624-1628
20. Venuta F., De Giacomo T., Rendina E.A., et al. Recovery of chronic renal impairment with sirolimus after lung transplantation. Ann Thorac Surg 78 (2004) 1940-1943
21. Shitrit D., Yussim A., and Kramer M.R. Role of siroliumus, a novel immunosuppressive drug in heart and lung transplantation. Respir Med 98 (2004) 892-897
22. Kahan B.D. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group. Lancet 356 (2000) 194-202
23. Chhajed P.N., Dickenmann M., Bubendorf L., et al. Patterns of pulmonary complications associated with sirolimus. Respiration 73 (2006) 367-374
24. Groetzner J., Kur F., Spelsberg F., et al. Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression. J Heart Lung Transplant 23 (2004) 632-638
25. Bloom R.D., and Doyle A.M. Kidney disease after heart and lung transplantation. Am J Transplant 6 (2006) 671-679
26. Takeuchi H., Okuyama K., Konno O., et al. Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters. Transplant Proc 37 (2005) 1745-1747
27. Grevel J., Welsh M.S., and Kahan B.D. Cyclosporine monitoring in renal transplantation: area under the curve monitoring is superior to trough-level monitoring. Ther Drug Monit 11 (1989) 246-248
28. Kuypers D.R. Immunosuppressive drug monitoring-what to use in clinical practice today to improve renal graft outcome. Transplant Int 18 (2005) 140-150
29. Saint-Marcoux F., Knoop C., Debord J., et al. Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies. Clin Pharmacokinet 44 (2005) 1317-1328
30. Tsai F.C., Marelli D., Bresson J., et al. Use of hearts transplanted from donors with atraumatic intracranial bleeds. J Heart Lung Transplant 21 (2002) 623-628
31. Yamani M.H., Lauer M.S., Starling R.C., et al. Impact of donor spontaneous intracranial hemorrhage on outcome after heart transplantation. Am J Transplant 4 (2004) 257-261
32. Johnston O., O'Kelly P., Spencer S., et al. The impact of donor spontaneous intracranial haemorrhage vs. other donors on long-term renal graft and patient survival. Clin Transplant 20 (2006) 91-95
33. Coopersmith C.M., Brennan D.C., Miller B., et al. Renal transplantation following previous heart, liver, and lung transplantation: an 8-year single-center experience. Surgery 130 (2001) 457-462